logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Amarin (AMRN) Plunges Again on FDA Announcement

By  +Follow October 30, 2013 9:36AM
Share:
Tickers Mentioned:

Amarin Pharmaceuticals (AMRN) took another hit Wednesday during a year that’s been a rough one for the company as a whole. Amarin was off over 14 percent in trading on Wednesday after the FDA told the company on Tuesday that its triglyceride-reducing drug, Vascepa, didn’t show strong enough results to merit approval.

Vascepa Fails to Show Results

The FDA contacted Amarin after market-close on Tuesday to report that Vascepa failed to reduce triglycerides enough to be marketed to patients for reducing the risk of cardiovascular disease. Vascepa is a prescription-strength supplement that uses Omega-3 fatty acids from fish oils. The drug was approved in 2012 for use in some patients with unusually high triglyceride levels, but the FDA reversed that ruling on Tuesday, sending shares lower.

This comes just two weeks after an FDA panel voted against approval of Vascepa and called for a lengthy and expensive study on the drug’s ability to prevent cardiovascular events like heart attacks, a decision that came as a surprise for many. The decision prompted Amarin to cut staff and prompted a nearly 60 percent decline in the company’s stock.

A Tough Year for Amarin

Today’s hit is a bad one. But in a year that’s seen shares plunge over 85 percent since Halloween in 2012, it’s probably not going to register for any long-time Amarin stockholders. The company has few options other than to continue running losses while engaging in the lengthy Vascepa study without a clear sense that there’s a light at the end of the tunnel.

With the layoffs last week, Amarin’s situation appears bleak, though not entirely unmanageable. Amarin believes that it has the cash on hand to make it through the next few years without raising additional capital.

“As of September 30, 2013, Amarin had cash, cash equivalents of approximately $226 million,” the company announced last Tuesday. “Amarin anticipates approximately $3 million in restructuring expense in association with this reduction in staffing. The company currently expects its cash burn for 2014 to be less than $80 million. The company has no plans for raising additional capital at this time. Amarin intends to continue its evaluation of priorities, opportunities and savings opportunities, including clinical trial costs. The company plans to provide additional details of its future spending and operational expectations in connection with its upcoming quarterly report.”

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for AMRN
Penny Stock Secret
26 Nov 14 12:44:11
$71,000 in ONE TRADE!! By Follwing Their Signals More Info Here http://t.co/SVqoMlijqL .. $PHMB $FNRC $AMRN
PHARMD
26 Nov 14 12:38:33
$srpt $amrn long term holds.
Sharon Yau
26 Nov 14 09:00:34
$amrn likey
Stockaholics
26 Nov 14 08:18:22
Our Penny Stock Pick On $STTK Gained 171% And Closed up Over 85%! Huge News: https://t.co/MMLz0V8NAH $PHMB $FNRC $AMRN
kontiki04
26 Nov 14 08:06:09
RT @green_day4me: $AMRN technical bounce off 10ema. looking for a breakout abv $1.37 w vol could send it into a gap fill from $1.50 to $1.80
greenday
26 Nov 14 07:56:55
$AMRN technical bounce off 10ema. looking for a breakout abv $1.37 w vol could send it into a gap fill from $1.50 to $1.80
Trader News Daily
26 Nov 14 07:51:30
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $FCEL $SPF $AXAS $AMRN $RGIN
MARK ROTH
26 Nov 14 07:31:25
RT BASF sells Norway plant, focused on Pharma grade Omega 3 business http://t.co/8rqXbzq1RJ $AMRN http://t.co/gw1k2dArk3 via @YahooFinance
MARK ROTH
26 Nov 14 07:31:03
RT EPA & DHA induce apoptosis, enhances drug sensitivity in multiple myeloma cells, not in normal cells http://t.co/CuHwBDkINB $AMRN
Jennifer smith
26 Nov 14 06:25:12
well another low volume day wishing all a happy Thanksgiving $NETE $CTRL $AMRN $VALE $CLF $MU $MTW
JohnCappello
26 Nov 14 04:03:46
EPA & DHA induce apoptosis, enhances drug sensitivity in multiple myeloma cells, not in normal cells http://t.co/E4gT0leMYg $AMRN
JohnCappello
26 Nov 14 03:37:21
BASF sells Norway plant, focused on Pharma grade Omega 3 business http://t.co/j3tMN5Aujf $AMRN
Stockaholics
25 Nov 14 19:45:29
Our Penny Stock Pick On $STTK Gained 171% And Closed up Over 85%! Huge News: https://t.co/AMUdfiTtGW $PHMB $FNRC $AMRN
Trader News Daily
25 Nov 14 16:33:24
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $FCEL $SPF $AXAS $AMRN $RGIN
$PENNY KING$
25 Nov 14 14:44:43
$AMRN dead money.......dead meat
Penny Stock Secret
25 Nov 14 12:37:27
This �Millionaire Maker� For Traders Shares His Secrets! Click here http://t.co/SVqoMlijqL .. $PHMB $FNRC $AMRN
MARK ROTH
25 Nov 14 11:53:47
RT EPA study circa 2007 worth reading; predicts R-I outcomes http://t.co/Anu9GfBFy2 $AMRN http://t.co/gw1k2dArk3 via @YahooFinance
JohnCappello
25 Nov 14 10:06:57
EPA study circa 2007 worth reading; predicts R-I outcomes http://t.co/JCgUGpg9XK $AMRN
Stockaholics
25 Nov 14 08:20:51
Our Platinum Penny Stock Pick On $STTK Is Up Over 128% This Morning. Huge News: http://t.co/MHaHGSIsXk $PHMB $FNRC $AMRN
JohnCappello
25 Nov 14 07:09:57
N3 PUFAs implicated in both CVD and depressive disorders.http://t.co/3AN1q6Y0Tb $AMRN
MARK ROTH
25 Nov 14 04:38:04
RT Beyond CVD, eicosapentaenoic acid (EPA) reduced growth of, experimental colorectal cancer liver metastases http://t.co/hcYqOuZOxv $AMRN
Trader News Daily
25 Nov 14 03:33:18
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $FCEL $SPF $AXAS $AMRN $RGIN
Stockaholics
25 Nov 14 01:54:22
Major New Penny Stock Pick Coming Today! Get It Early: https://t.co/2B2qAoeDYm $PHMB $FNRC $AMRN
JohnCappello
25 Nov 14 01:33:41
Beyond CVD, eicosapentaenoic acid (EPA) reduced growth of, experimental colorectal cancer liver metastases http://t.co/tlIJh5lJqU $AMRN
Trader News Daily
24 Nov 14 19:56:31
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $FCEL $SPF $AXAS $AMRN $RGIN
NathanAaron
24 Nov 14 18:00:38
Seems $amrn had also withdrawn the 1.25 net revenue per pill they've guided to
Stockaholics
24 Nov 14 17:08:18
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $PHMB $FNRC $AMRN
Trader News Daily
24 Nov 14 15:45:59
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $FCEL $SPF $AXAS $AMRN $RGIN
Penny Stock Secret
24 Nov 14 13:27:06
Premium Alerts Ranked #1 For Gains 2534% Last Week http://t.co/SVqoMlijqL .. $PHMB $FNRC $AMRN
Joseph Hopkins
24 Nov 14 10:58:40
@BullRunner911 Agreed here. Wouldn't be surprise to see $AMRN close at or about 1.25 today. But, overall solid price action. Nice LT hold.
Bullrunner911
24 Nov 14 10:21:32
$AMRN AMRN is basing for the next leg up. The action is not bad after such a large % bounce off the bottom
EvaluatePharma
24 Nov 14 10:20:19
Here's last week’s Top 15 market gains and losses... $CLDX +47%, $AMRN +38%, $NBS -35%, $BIND -35% http://t.co/UvN8BwPjYW
Zenhunter
24 Nov 14 09:06:15
Added more $AMRN to round up investment size. Also add a bit more $LRAD. Now 100% invested/speculated.
Stockaholics
24 Nov 14 08:44:51
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $PHMB $FNRC $AMRN
Trader News Daily
24 Nov 14 08:12:37
Wow http://t.co/PeRPkZkWiw just posted last weeks results. +429%. Crazy. They offer a free trial too. $FCEL $SPF $AXAS $AMRN $RGIN
kontiki04
24 Nov 14 07:58:58
RT @BullRunner911: $AMRN 200 day moving average is falling every day
Bullrunner911
24 Nov 14 07:50:56
$AMRN 200 day moving average is falling every day
biotechnicality
24 Nov 14 07:48:29
@mdsearchlight yes. Own a small amount; less than 1% of my retirement account. I own primarily $cemp & unfortunately $amrn in the bio realm.
Bullrunner911
24 Nov 14 07:32:38
$AMRN 150k bid at 1.30. So who are all these block bidders every day?
kontiki04
24 Nov 14 07:04:37
$amrn turns green
Shane Blackmon
24 Nov 14 05:32:53
$GALE $AMRN look good for possible Thanksgiving week moves, $GERN already going parabolic
justamoneymatter
24 Nov 14 03:59:01
FREE TRADING CHAT http://t.co/VibxUfrxqa $GERN $NBS $VGGL $SPEX $OXGN $SNSS $AMRN $RADA $FWM $AMCN $MDO $EDAP $FOLD $MAG $NETE
justamoneymatter
24 Nov 14 03:58:15
FREE TRADING CHAT $GERN $NBS $VGGL $SPEX $OXGN $SNSS $AMRN $RADA $FWM $AMCN $MDO $EDAP $FOLD $MAG $NETE
C-Dub
24 Nov 14 02:33:29
$ECRY $DEWM $DROP $MNZO $INO $GPRO - Bounce keying 70 or short $AMRN - Break 1.38/1.50 for a nice run to 2. Also watch for nice Holiday runs
Marian Zöllkau
24 Nov 14 00:35:25
Watchlist 11/24/2014: http://t.co/Dp0LNxyPPu $CANF $FWM $GERN $GPRO $AEMD $ANIP $EIGI $AMRN $MOLG $FB $TWTR $SPY $AAPL
T Abuhasna
23 Nov 14 22:39:49
Update: Amarin Earnings Show It Blew Its Chance At 2014 Profitability $AMRN http://t.co/MbiRZl7F8g
Seeking Alpha - All
23 Nov 14 22:13:44
Update: Amarin Earnings Show It Blew Its Chance At 2014 Profitability http://t.co/fnrOQaiLFk $AMRN
Rick Patterson
23 Nov 14 21:20:41
Watchlist #Stocks $CANF $TAUG $QASP $ICBU #Healthcare / Biotech Bouncers $EPRS $PTIE $OGEN $EDAP $AMRN
Rick Patterson
23 Nov 14 21:12:57
#Biotech Bounce / Healthcare Watchlist $EPRS $PTIE $OGEN $EDAP $AMRN #Stocks
Stockaholics
23 Nov 14 20:00:43
578% Gains On Penny Stocks in one month! Plus a New Pick Is Coming: http://t.co/2W3yKD2d5Q $PHMB $FNRC $AMRN
				
				
By  +Follow October 30, 2013 9:36AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.